Matt Holt

Managing Director, New Mountain Capital

 

Matt Holt, Managing Director, joined New Mountain in 2001. He serves as the Deputy Head of Private Equity and focuses on growth buyouts across a range of industries including healthcare products, health technology, materials and infrastructure. He previously worked in the Mergers and Acquisitions Group at Lehman Brothers from 1999 to 2001. He serves as the Lead Director or Chairman of Avantor, Inc., CIOX Health, Signify Health, Convey Health Solutions, Inc., Cytel, Revint Solutions, W20 and Zep, Inc. He also serves as a Director of Aceto, Topix Pharmaceuticals, Gelest, and TRC Companies. Mr. Holt has previously served as Lead Director of Bellerophon Therapeutics, Inc., Equian LLC, Ikaria, Inc., Nusil Technology LLC, and Director of MailSouth.